S.L. 458.35 · Pharmacovigilance Regulations (S.L. 458.35)
S.L. 458.35 Art. 24Detection of duplicates.
The Authority shall collaborate with the Agency and the marketing authorisation holders in the detection of duplicates of suspected adverse reaction reports.